Our results demonstrated that TG101209 could induce BL cell differentiation toward mature lymphoid or plasmacytoid cells with the morphological features of differentiation and enhanced CD138 and CD38 expression and weaker CD19 and CD10 expression (Fig. 3). This evidence concerns the gene CD38 and Burkitt lymphoma.